194 related articles for article (PubMed ID: 27716898)
1. Distinct patterns of cytolytic T-cell activation by different tumour cells revealed by Ca
Frick M; Mouchacca P; Verdeil G; Hamon Y; Billaudeau C; Buferne M; Fallet M; Auphan-Anezin N; Schmitt-Verhulst AM; Boyer C
Immunology; 2017 Feb; 150(2):199-212. PubMed ID: 27716898
[TBL] [Abstract][Full Text] [Related]
2. Visualization of cytolytic T cell differentiation and granule exocytosis with T cells from mice expressing active fluorescent granzyme B.
Mouchacca P; Schmitt-Verhulst AM; Boyer C
PLoS One; 2013; 8(6):e67239. PubMed ID: 23840635
[TBL] [Abstract][Full Text] [Related]
3. Intramuscular electroporation of a P1A-encoding plasmid vaccine delays P815 mastocytoma growth.
Vandermeulen G; Uyttenhove C; De Plaen E; Van den Eynde BJ; Préat V
Bioelectrochemistry; 2014 Dec; 100():112-8. PubMed ID: 24342164
[TBL] [Abstract][Full Text] [Related]
4. Localization of two cytotoxic T lymphocyte epitopes and three anchoring residues on a single nonameric peptide that binds to H-2Ld and is recognized by cytotoxic T lymphocytes against mouse tumor P815.
Van den Eynde B; Mazarguil H; Lethé B; Laval F; Gairin JE
Eur J Immunol; 1994 Nov; 24(11):2740-5. PubMed ID: 7525302
[TBL] [Abstract][Full Text] [Related]
5. Cooperative action of CD8 T lymphocytes and natural killer cells controls tumour growth under conditions of restricted T-cell receptor diversity.
Shanker A; Buferne M; Schmitt-Verhulst AM
Immunology; 2010 Jan; 129(1):41-54. PubMed ID: 20050329
[TBL] [Abstract][Full Text] [Related]
6. Co-expression of P1A35-43/beta2m fusion protein and co-stimulatory molecule CD80 elicits effective anti-tumor immunity in the P815 mouse mastocytoma tumor model.
Zhang X; Mei W; Zhang L; Yu H; Zhao X; Fan X; Qian G; Ge S
Oncol Rep; 2009 Nov; 22(5):1213-20. PubMed ID: 19787242
[TBL] [Abstract][Full Text] [Related]
7. Distinct role of lymphocyte function-associated antigen-1 in mediating effective cytolytic activity by cytotoxic T lymphocytes.
Anikeeva N; Somersalo K; Sims TN; Thomas VK; Dustin ML; Sykulev Y
Proc Natl Acad Sci U S A; 2005 May; 102(18):6437-42. PubMed ID: 15851656
[TBL] [Abstract][Full Text] [Related]
8. The expression of mouse gene P1A in testis does not prevent safe induction of cytolytic T cells against a P1A-encoded tumor antigen.
Uyttenhove C; Godfraind C; Lethé B; Amar-Costesec A; Renauld JC; Gajewski TF; Duffour MT; Warnier G; Boon T; Van den Eynde BJ
Int J Cancer; 1997 Jan; 70(3):349-56. PubMed ID: 9033639
[TBL] [Abstract][Full Text] [Related]
9. The shared tumor-specific antigen encoded by mouse gene P1A is a target not only for cytolytic T lymphocytes but also for tumor rejection.
Brändle D; Bilsborough J; Rülicke T; Uyttenhove C; Boon T; Van den Eynde BJ
Eur J Immunol; 1998 Dec; 28(12):4010-9. PubMed ID: 9862337
[TBL] [Abstract][Full Text] [Related]
10. Enhancing CTL responses to melanoma cell vaccines in vivo: synergistic increases obtained using IFNgamma primed and IFNbeta treated B7-1+ B16-F10 melanoma cells.
Dezfouli S; Hatzinisiriou I; Ralph SJ
Immunol Cell Biol; 2003 Dec; 81(6):459-71. PubMed ID: 14636243
[TBL] [Abstract][Full Text] [Related]
11. Specific lysis of murine cells expressing HLA molecules by allospecific human and murine H-2-restricted anti-HLA T killer lymphocytes.
Achour A; Begue B; Gomard E; Paul P; Sayagh B; Van Pel A; Levy JP
Eur J Immunol; 1986 Jun; 16(6):597-604. PubMed ID: 3522244
[TBL] [Abstract][Full Text] [Related]
12. Induction of melanoma antigen-specific cytotoxic T lymphocytes in vitro by stimulation with B7-expressing human melanoma cell lines.
Fenton RG; Turcovski-Corrales SM; Taub DD
J Immunother; 1998 Mar; 21(2):95-108. PubMed ID: 9551360
[TBL] [Abstract][Full Text] [Related]
13. Tumor necrosis factor gene-engineered J558 tumor cell-released exosomes stimulate tumor antigen P1A-specific CD8+ CTL responses and antitumor immunity.
Xie Y; Bai O; Zhang H; Li W; Xiang J
Cancer Biother Radiopharm; 2010 Feb; 25(1):21-8. PubMed ID: 20187793
[TBL] [Abstract][Full Text] [Related]
14. Modulation of cytolytic T lymphocyte functions by an inhibitor of serine/threonine phosphatase, okadaic acid. Enhancement of cytolytic T lymphocyte-mediated cytotoxicity.
Taffs RE; Redegeld FA; Sitkovsky MV
J Immunol; 1991 Jul; 147(2):722-8. PubMed ID: 1649222
[TBL] [Abstract][Full Text] [Related]
15. The exocytosis of lytic granules is impaired in Vti1b- or Vamp8-deficient CTL leading to a reduced cytotoxic activity following antigen-specific activation.
Dressel R; Elsner L; Novota P; Kanwar N; Fischer von Mollard G
J Immunol; 2010 Jul; 185(2):1005-14. PubMed ID: 20543108
[TBL] [Abstract][Full Text] [Related]
16. Protein tyrosine kinase p56-Lck regulates lymphocyte function-associated 1 adhesion molecule expression, granule exocytosis, and cytolytic effector function in a cloned T cell.
Torigoe T; Millan JA; Chan KW; Taichman R; Brian AA; Reed JC; Tachman R [corrected to Taichman R]
J Exp Med; 1994 Sep; 180(3):1115-27. PubMed ID: 7914906
[TBL] [Abstract][Full Text] [Related]
17. CD2/LFA-3 or LFA-1/ICAM-1 but not CD28/B7 interactions can augment cytotoxicity by virus-specific CD8+ cytotoxic T lymphocytes.
de Waal Malefyt R; Verma S; Bejarano MT; Ranes-Goldberg M; Hill M; Spits H
Eur J Immunol; 1993 Feb; 23(2):418-24. PubMed ID: 7679643
[TBL] [Abstract][Full Text] [Related]
18. Clonal heterogeneity in LFA-3 and ICAM-1 requirement for lysis by alloreactive T lymphocytes.
Galocha B; López D; López de Castro JA
J Immunol; 1993 Mar; 150(5):1653-62. PubMed ID: 7679690
[TBL] [Abstract][Full Text] [Related]
19. Cytolytic T lymphocytes recognize an antigen encoded by MAGE-A10 on a human melanoma.
Huang LQ; Brasseur F; Serrano A; De Plaen E; van der Bruggen P; Boon T; Van Pel A
J Immunol; 1999 Jun; 162(11):6849-54. PubMed ID: 10352307
[TBL] [Abstract][Full Text] [Related]
20. CD103 or LFA-1 engagement at the immune synapse between cytotoxic T cells and tumor cells promotes maturation and regulates T-cell effector functions.
Franciszkiewicz K; Le Floc'h A; Boutet M; Vergnon I; Schmitt A; Mami-Chouaib F
Cancer Res; 2013 Jan; 73(2):617-28. PubMed ID: 23188505
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
